News

A study that tracked healthcare staff during the COVID-19 pandemic has revealed that those staff who did not contract the disease pre-vaccines had IgA antibodies in the respiratory tract, which protected them from the SARS-CoV-2 virus.

New software can scan a target molecule then generate proteins that bind with high affinity to the target, proposing an alternative strategy to develop drugs for cancer, diabetes and beyond.

An obscure species of wild grass contains “blockbuster” disease resistance that can be cross bred into wheat to give immunity against one of the deadliest crop pathogens.

Researchers have validated a new antibody test to diagnose multiple sclerosis.

A new study shows how antibodies select the antigens that they bind to, as they navigate the surface of pathogens such as coronaviruses.

The viral protein Vpu, expressed by Simian immunodeficiency virus, targets tetherin in both humans and monkeys but uses different mechanisms to do so.

New technology has been able to track T cell responses following infection with SARS-CoV-2 and has revealed that after 15 months, there are still sustained levels of cells able to recognize the SARS-CoV-2 spike protein.

Scientists showed that sulforaphane, a plant-derived chemical, known as a phytochemical, already found to have anti-cancer effects, can inhibit the replication of SARS-CoV-2, the coronavirus that causes COVID-19, and another human coronavirus in cells and mice.

Scientists are working to understand the effects of micro- and nanoplastics on the gut microbiome as well as the molecular mechanisms that permit the uptake of these plastics into the gastrointestinal tract.

Researchers have harnessed a fungus to convert food waste into sustainable faux leather, as well as paper products and cotton substitutes, with properties comparable to the traditional materials.